tiprankstipranks
Palisade Bio, Inc. (DE:7NS0)
NASDAQ:7NS0
Germany Market
7NS0
Palisade Bio
RESEARCH TOOLSreports

Palisade Bio (7NS0) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

7NS0 Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Palisade
Bio
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

7NS0 Stock 12 Month Forecast

Average Price Target

€6.06
▲(21.01% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Palisade Bio in the last 3 months. The average price target is €6.06 with a high forecast of €6.93 and a low forecast of €4.33. The average price target represents a 21.01% change from the last price of €5.01.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"€3","4":"€4","5":"€5","6":"€6","7":"€7"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6.92896256,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€6.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.06284224,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€6.06</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.3306016000000005,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€4.33</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,4,5,6,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.007,5.154843273846153,5.302686547692307,5.450529821538462,5.598373095384615,5.746216369230769,5.894059643076923,6.0419029169230765,6.189746190769231,6.337589464615385,6.4854327384615384,6.633276012307693,6.781119286153846,{"y":6.92896256,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.007,5.088218633846154,5.169437267692308,5.250655901538462,5.331874535384615,5.413093169230769,5.494311803076923,5.575530436923077,5.656749070769231,5.737967704615385,5.819186338461538,5.900404972307692,5.981623606153846,{"y":6.06284224,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.007,4.9549693538461534,4.902938707692307,4.850908061538461,4.798877415384616,4.746846769230769,4.694816123076923,4.642785476923077,4.590754830769231,4.5387241846153845,4.486693538461539,4.434662892307693,4.382632246153847,{"y":4.3306016000000005,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.007,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.007,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€6.93Average Price Target€6.06Lowest Price Target€4.33
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:7NS0
Mitchell Kapoor
H.C. Wainwright
H.C. Wainwright
€6.06
Buy
21.01%
Upside
Reiterated
08/11/26
Kapoor Reiterates Buy on Palisade Bio, Maintains $7 Price Target as PALI-2108 Advances into Phase 2 IBD Trials
Oppenheimer Analyst forecast on DE:7NS0
Leland Gershell
Oppenheimer
Oppenheimer
€6.93
Buy
38.30%
Upside
Reiterated
08/11/26
Palisade Bio (PALI) Receives a Buy from Oppenheimer
Stifel Nicolaus Analyst forecast on DE:7NS0
Alex Thompson CFA
Stifel Nicolaus
Stifel Nicolaus
€4.33
Buy
-13.56%
Downside
Reiterated
07/06/26
Analysts Are Bullish on Top Healthcare Stocks: Coya Therapeutics, Inc. (COYA), Palisade Bio (PALI)
Maxim Group Analyst forecast on DE:7NS0
Naz Rahman
Maxim Group
Maxim Group
€6.93
Buy
38.30%
Upside
Reiterated
06/29/26
Analysts' Top Healthcare Picks: Palisade Bio (PALI), Sarepta Therapeutics (SRPT)
B. Riley Securities Analyst forecast on DE:7NS0
William Wood
B. Riley Securities
B. Riley Securities
€6.06
Buy
21.01%
Upside
Reiterated
06/02/26
Palisade Bio (PALI) Gets a Buy from B. Riley Securities
Piper Sandler Analyst forecast on DE:7NS0
Yasmeen Rahimi
Piper Sandler
Piper Sandler
€21.65
Buy
332.20%
Upside
Reiterated
04/13/26
Piper Sandler Reaffirms Their Buy Rating on Palisade Bio (PALI)
Wolfe Research Analyst forecast on DE:7NS0
Andy Chen
Wolfe Research
Wolfe Research
€6.06
Buy
21.01%
Upside
Initiated
04/08/26
Palisade Bio initiated with an Outperform at Wolfe ResearchPalisade Bio initiated with an Outperform at Wolfe Research
Clear Street Analyst forecast on DE:7NS0
Kaveri Pohlman
Clear Street
Clear Street
€10.39
Buy
107.45%
Upside
Reiterated
03/31/26
Palisade Bio reaction to PALI-2108 data 'looks misaligned', says Clear StreetPalisade Bio reaction to PALI-2108 data 'looks misaligned', says Clear Street
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:7NS0
Mitchell Kapoor
H.C. Wainwright
H.C. Wainwright
€6.06
Buy
21.01%
Upside
Reiterated
08/11/26
Kapoor Reiterates Buy on Palisade Bio, Maintains $7 Price Target as PALI-2108 Advances into Phase 2 IBD Trials
Oppenheimer Analyst forecast on DE:7NS0
Leland Gershell
Oppenheimer
Oppenheimer
€6.93
Buy
38.30%
Upside
Reiterated
08/11/26
Palisade Bio (PALI) Receives a Buy from Oppenheimer
Stifel Nicolaus Analyst forecast on DE:7NS0
Alex Thompson CFA
Stifel Nicolaus
Stifel Nicolaus
€4.33
Buy
-13.56%
Downside
Reiterated
07/06/26
Analysts Are Bullish on Top Healthcare Stocks: Coya Therapeutics, Inc. (COYA), Palisade Bio (PALI)
Maxim Group Analyst forecast on DE:7NS0
Naz Rahman
Maxim Group
Maxim Group
€6.93
Buy
38.30%
Upside
Reiterated
06/29/26
Analysts' Top Healthcare Picks: Palisade Bio (PALI), Sarepta Therapeutics (SRPT)
B. Riley Securities Analyst forecast on DE:7NS0
William Wood
B. Riley Securities
B. Riley Securities
€6.06
Buy
21.01%
Upside
Reiterated
06/02/26
Palisade Bio (PALI) Gets a Buy from B. Riley Securities
Piper Sandler Analyst forecast on DE:7NS0
Yasmeen Rahimi
Piper Sandler
Piper Sandler
€21.65
Buy
332.20%
Upside
Reiterated
04/13/26
Piper Sandler Reaffirms Their Buy Rating on Palisade Bio (PALI)
Wolfe Research Analyst forecast on DE:7NS0
Andy Chen
Wolfe Research
Wolfe Research
€6.06
Buy
21.01%
Upside
Initiated
04/08/26
Palisade Bio initiated with an Outperform at Wolfe ResearchPalisade Bio initiated with an Outperform at Wolfe Research
Clear Street Analyst forecast on DE:7NS0
Kaveri Pohlman
Clear Street
Clear Street
€10.39
Buy
107.45%
Upside
Reiterated
03/31/26
Palisade Bio reaction to PALI-2108 data 'looks misaligned', says Clear StreetPalisade Bio reaction to PALI-2108 data 'looks misaligned', says Clear Street
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Palisade Bio

3 Months
Naz RahmanMaxim Group
Success Rate
6/23 ratings generated profit
26%
Average Return
-13.87%
Copying Naz Rahman's trades and holding each position for 3 Months would result in 26.09% of your transactions generating a profit, with an average return of -13.87% per trade.
1 Year
Naz RahmanMaxim Group
Success Rate
7/23 ratings generated profit
30%
Average Return
-12.29%
Copying Naz Rahman's trades and holding each position for 1 Year would result in 30.43% of your transactions generating a profit, with an average return of -12.29% per trade.
2 Years
Naz RahmanMaxim Group
Success Rate
7/23 ratings generated profit
30%
Average Return
-2.76%
Copying Naz Rahman's trades and holding each position for 2 Years would result in 30.43% of your transactions generating a profit, with an average return of -2.76% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

7NS0 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
11
10
8
6
7
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
10
8
6
7
In the current month, 7NS0 has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 7NS0 average Analyst price target in the past 3 months is 6.06.
Each month's total comprises the sum of three months' worth of ratings.

7NS0 Financial Forecast

7NS0 Earnings Forecast

Next quarter’s earnings estimate for 7NS0 is -€0.05 with a range of -€0.06 to -€0.04. The previous quarter’s EPS was -€0.04. 7NS0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.30% of the time in the same period. In the last calendar year 7NS0 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 7NS0 is -€0.05 with a range of -€0.06 to -€0.04. The previous quarter’s EPS was -€0.04. 7NS0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.30% of the time in the same period. In the last calendar year 7NS0 has Performed in-line its overall industry.

7NS0 Sales Forecast

Next quarter’s sales forecast for 7NS0 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €433.06K. 7NS0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.97% of the time in the same period. In the last calendar year 7NS0 has Performed in-line its overall industry.
Next quarter’s sales forecast for 7NS0 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €433.06K. 7NS0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.97% of the time in the same period. In the last calendar year 7NS0 has Performed in-line its overall industry.

7NS0 Stock Forecast FAQ

What is DE:7NS0’s average 12-month price target, according to analysts?
Based on analyst ratings, Palisade Bio, Inc.’s 12-month average price target is 6.06.
    What is DE:7NS0’s upside potential, based on the analysts’ average price target?
    Palisade Bio, Inc. has 21.01% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Palisade Bio, Inc. a Buy, Sell or Hold?
          Palisade Bio, Inc. has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Palisade Bio, Inc.’s share price target?
            The average share price target for Palisade Bio, Inc. is 6.06. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €6.93 ,and the lowest forecast is €4.33. The average share price target represents 21.01% Increase from the current price of €5.01.
              What do analysts say about Palisade Bio, Inc.?
              Palisade Bio, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of Palisade Bio, Inc.?
                To buy shares of DE:7NS0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.